Wedbush Lowers C3.ai Price Target to $35

Analyst: Daniel Ives 1 min read Reproduced verbatim
Rating
Outperform
Target
$35
from $45 (−22%)
Outcome
Missed
within 12 months

The median of 3 current targets on C3.ai is $12. Wedbush has reached 68% of its year-old targets (34 scored).

Wedbush and C3.ai logos

What the analyst said

Wedbush analyst Daniel Ives lowered the price target on c3.ai (NYSE: AI) to $35.00 (from $45.00) while maintaining an Outperform rating.

Cite this note: Price Target, "Wedbush Lowers C3.ai Price Target to $35," May 29, 2025. https://price-target.com/2025/05/29/179157/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AI trades at $9.13. The 3 analysts who set a target in the last 3 months range from $7 to $12.50, with a median of $12. This $35 target is 192% above the median, the highest on the Street.

Since the note AI has moved −60% (from $23.02). The 12-month window closed on May 29, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note AI closed at $10.77, 69% below the $35 target, and it moved the other way.

Firm track recordWedbush: 68% of its 34 targets at least a year old were reached within 12 months (#25 of 29 firms). Accuracy ranking →

Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.